Baidu
map

AP&T: 抑郁症与成人中的非酒精性脂肪肝相关

2019-09-07 MedSci MedSci原创

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px '.PingFang SC'; color: #454545} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px 'Helvetica Neue'; color: #454545; min-height: 14.0p

背景

目前,抑郁症与非酒精性脂肪性肝病(NAFLD)之间的关系尚未明确界定。本项研究旨在探究抑郁症是否与NAFLDNAFLD相关的晚期纤维化的关系。


方法

研究人员对2005-20017年间所有大于20岁以上的美国青少年进行了横断面分析。使用患者健康问卷(PHQ-9)评估抑郁引起的抑郁和功能障碍。在没有其他慢性肝病原因的情况下,通过利用美国脂肪肝指数(USFLI),肝脂肪变性指数(HSI)和脂肪肝指数(FLI)来定义NAFLD。由Fibrosis-4评分定义NAFLD中存在还是不存在晚期纤维化。


结果

10484名受试者(平均年龄47.0岁; 48.8%男性)中,NAFLD患者的抑郁和功能障碍的患病率高于无患者。与没有抑郁症的受试者相比,抑郁症患者的NAFLD可能性高1.6-2.2倍。在我们的多变量分析中,抑郁症与使用USFLINAFLD风险增加相关(比值比[OR] 1.48 95%置信区间[CI] 1.17-1.87),HSIOR 1.51 95CI 1.04-2.19)和FLIOR 2.01 95CI 1.65-2.48)。该模型中糖尿病,肥胖和脂质谱的增加降低了抑郁症危险率,抑郁与NAFLD相关的晚期纤维化无关。


结论

抑郁症与NAFLD独立相关。


原始出处:

Donghee Kim. Et al. Depression is associated with non‐alcoholic fatty liver disease among adults in the United States. Alimentary Pharmacology & Therapeutics. 2019.


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1980517, encodeId=ab7f198051e08, content=<a href='/topic/show?id=099f9548ed7' target=_blank style='color:#2F92EE;'>#酒精性脂肪肝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95487, encryptionId=099f9548ed7, topicName=酒精性脂肪肝)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Wed Dec 11 17:56:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673522, encodeId=f7bb16e35229a, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Oct 17 17:56:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676511, encodeId=3b9416e6511d5, content=<a href='/topic/show?id=397299e19c7' target=_blank style='color:#2F92EE;'>#非酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99719, encryptionId=397299e19c7, topicName=非酒精性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Sep 20 20:56:00 CST 2019, time=2019-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372516, encodeId=528c3e251602, content=663, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Tue Sep 10 00:10:57 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1980517, encodeId=ab7f198051e08, content=<a href='/topic/show?id=099f9548ed7' target=_blank style='color:#2F92EE;'>#酒精性脂肪肝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95487, encryptionId=099f9548ed7, topicName=酒精性脂肪肝)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Wed Dec 11 17:56:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673522, encodeId=f7bb16e35229a, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Oct 17 17:56:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676511, encodeId=3b9416e6511d5, content=<a href='/topic/show?id=397299e19c7' target=_blank style='color:#2F92EE;'>#非酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99719, encryptionId=397299e19c7, topicName=非酒精性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Sep 20 20:56:00 CST 2019, time=2019-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372516, encodeId=528c3e251602, content=663, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Tue Sep 10 00:10:57 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1980517, encodeId=ab7f198051e08, content=<a href='/topic/show?id=099f9548ed7' target=_blank style='color:#2F92EE;'>#酒精性脂肪肝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95487, encryptionId=099f9548ed7, topicName=酒精性脂肪肝)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Wed Dec 11 17:56:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673522, encodeId=f7bb16e35229a, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Oct 17 17:56:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676511, encodeId=3b9416e6511d5, content=<a href='/topic/show?id=397299e19c7' target=_blank style='color:#2F92EE;'>#非酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99719, encryptionId=397299e19c7, topicName=非酒精性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Sep 20 20:56:00 CST 2019, time=2019-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372516, encodeId=528c3e251602, content=663, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Tue Sep 10 00:10:57 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1980517, encodeId=ab7f198051e08, content=<a href='/topic/show?id=099f9548ed7' target=_blank style='color:#2F92EE;'>#酒精性脂肪肝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95487, encryptionId=099f9548ed7, topicName=酒精性脂肪肝)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Wed Dec 11 17:56:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673522, encodeId=f7bb16e35229a, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Oct 17 17:56:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676511, encodeId=3b9416e6511d5, content=<a href='/topic/show?id=397299e19c7' target=_blank style='color:#2F92EE;'>#非酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99719, encryptionId=397299e19c7, topicName=非酒精性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Sep 20 20:56:00 CST 2019, time=2019-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372516, encodeId=528c3e251602, content=663, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Tue Sep 10 00:10:57 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
    2019-09-10 百草

    663

    0

相关资讯

IBD: 焦虑程度可预测炎症性肠病的不良结果

患有炎症性肠病(IBD)的患者具有更高的精神疾病,但尚不清楚合并精神疾病的患者是否具有较高的预后不良风险。本项研究的目的是确定与没有焦虑和/或抑郁的IBD患者相比,患有IBD且患有焦虑和/或抑郁症的患者是否更可能具有较差的预后。

GUT:抑郁药物可以通过缓解抑郁症状来减炎症性肠病的发病风险

有文献报道抑郁症与炎症性肠病(IBD)的发病有关,但抗抑郁药对IBD的影响尚未得到充分研究。因此,研究人员评估了抑郁症和抗抑郁治疗对IBD发展的影响。

ARCH GEN PSYCHIAT :情绪障碍发作与分娩有关

    根据在线发表于12月17日的《普通精神病学文献》上的一篇报告,伴有情绪障碍的妊娠妇女70%以上发生至少1次与分娩相关的情绪障碍发作,与妊娠相关的情绪障碍发作相对较少。   威尔士Cardiff大学精神药物和临床神经科学研究所的Ian Jones医生及其同事利用来自两项关于情绪障碍的临床和遗传学研究的数据,评估了与分娩相关的多种精神障碍的发生情况。一个研究队列中纳入

Biol Psychiatry:实验药物有望‘在数分钟内’帮助治疗抑郁

       12月3日在线发表于《生物精神病学》的新研究表明,尽管一种被描述为“友好版氯胺酮”的新型实验药物似乎可快速减少抑郁症状,但其效应可能不会长期持续存在。        由国立精神卫生研究所(NIMH)的研究者进行的一项小型随机交叉研究显示,单次滴注AZD6765后,近32%的难治性重性抑郁障碍

APA:米氮平在抑郁症治疗中的作用

      米氮平是第一个去甲肾上腺素( NE)能和特异性5一羟色胺(5-HT)能抗抑郁药(NaSSA),美国精神病学学会(American Psychiatric  Associalion)于2010年10月正式发布的第3版《抑郁症治疗指南》(以下简称《2010版指南》)中,将米氮平推荐为不同抑郁症治疗阶段以及多种特殊人群的治

GUT: 抑郁会增加炎症性肠病的风险

有研究报道抑郁症与IBD有关,但抗抑郁药对IBD的影响尚未得到很好的研究。本项研究旨在评估抑郁症和抗抑郁治疗对IBD发展的影响。

Baidu
map
Baidu
map
Baidu
map